<DOC>
	<DOCNO>NCT02384811</DOCNO>
	<brief_summary>The primary object trial evaluate 2-year local control rate add extensive clinical target volume postoperative radiotherapy esophageal squamous cell carcinoma .</brief_summary>
	<brief_title>Phase II Study Extensive Clinical Target Volumes Postoperative Radiotherapy Esophageal Squamous Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Joined study voluntarily sign informed consent form ; Age 1875；ECOG 02 Esophageal squamous cell carcinoma , radical surgery ≤3 month , R0 resection . The operative incision heal well . T34N0M0 , T14N13M0 ( accord AJCC2009 ) No radiotherapy , chemotherapy treatment pre ( post ) surgery PS ECOG 02 Life expectancy 3 month Hemoglobin ( Hb ) ≥9 g/dL • WBC≥3x109/L , Neutrophils ( ANC ) ≥1.5x109/L • platelet count ( Pt ) ≥100x 109/L • Hepatic function : ALAT ASAT &lt; 2.5 x ULN , TBIL &lt; 1.5 x ULN • Renal function : creatinine &lt; 1.5 x ULN No immunodeficiency Use effective contraceptive adult prevent pregnancy . Complete esophageal obstruction surgery , Esophageal perforation , Haematemesis Other malignant tumor , except skin basal cell carcinoma , cervical carcinoma situ , survive evidence disease 3 year Participation interventional clinical trial within 30 day Pregnant breastfeed woman people birthperiod refused take contraceptive Drug addiction , Alcoholism AIDS Uncontrolled seizure psychiatric disease , loss control behavior Unsuitable enrol trial opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Esophageal squamous cell carcinoma</keyword>
	<keyword>postoperative radiotherapy</keyword>
</DOC>